Home > News > Breast Cancer Drug Offers Better Responses
May 6th, 2005
Breast Cancer Drug Offers Better Responses
One of the latest, most promising treatments for some women with metastatic breast cancer is a new drug that increases the response rate of tumors and causes fewer side effects, researchers say.
The technology behind the drug, nanoparticle albumin-bound paclitaxel (nab-paclitaxel or AbraxaneTM) marks a breakthrough, say Vicente Valero M.D., and Edgardo Rivera, M.D., both in the Department of Breast Medical Oncology at M. D. Anderson.
American Pharmaceutical Partners
Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014
NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014
SentiMag® Now Available in Australia and New Zealand July 21st, 2014
More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014
UCF Nanotech Spinout Developing Revolutionary Battery Technology: Power the Next Generation of Electronics with Carbon July 23rd, 2014
Deadline Announced for Registration in 7th Int'l Nanotechnology Festival in Iran July 23rd, 2014
A Crystal Wedding in the Nanocosmos July 23rd, 2014